# Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone

> **NCT01739335** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 81 (actual)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Mifepristone Oral Tablet [Korlym]
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT01739335
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-19
- **Primary completion:** 2016-09-19
- **Final completion:** 2016-11-16
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739335, "Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01739335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*